Stockreport

Valneva Successfully Expands Access to Asia for its Chikungunya Vaccine with Serum Institute of India

Valneva SE - American Depositary Shares  (VALN) 
PDF Saint-Herblain (France), Pune, (India), December 19, 2024 – Valneva SE (“Valneva” or “the Company”), a specialty vaccine company, and Serum Institute of India (SII), the [Read more]